Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein
NCT05922852 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2023-06-28
Summary
The purpose of this study is to determine whether the combination of SGLT2i and ARNI in type 2 diabetic patients with combined albuminuria could reduce urinary protein more significantly than single agent.
Conditions
- Type 2 Diabetes
- Antidiabetic Drugs
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-02-28
- Completion
- 2024-02-28
Countries
- China
Study Locations
More Related Trials
-
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
NCT06068439 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
NCT06610526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
NCT03983551 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
NCT03573102 ·Status: UNKNOWN ·Phase: PHASE4
-
Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
NCT02796170 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
NCT03190694 ·Status: COMPLETED ·Phase: PHASE2
-
SGLT2-inhibitors on PC-AKI
NCT06491953 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
NCT04707508 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
NCT02035891 ·Status: UNKNOWN ·Phase: NA
-
To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy
NCT05047471 ·Status: UNKNOWN
-
Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
NCT02807974 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
NCT02517320 ·Status: COMPLETED ·Phase: PHASE2
-
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
NCT05998837 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
NCT05373004 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Treatment of Patients With Diabetic Kidney Disease
NCT06187493 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria
NCT02410499 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
NCT01464320 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
NCT06666283 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of PH3 in Diabetic Nephropathy
NCT01068041 ·Status: COMPLETED ·Phase: PHASE2
-
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
NCT06031389 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
NCT06182891 ·Status: COMPLETED ·Phase: NA
-
Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes
NCT02914691 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
NCT03159832 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
NCT01316068 ·Status: UNKNOWN ·Phase: PHASE4